鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/09/15 | 3,025 | 3,060 | 3,015 | 3,035 | -45 | -1.5% | 33,200 |
2021/09/14 | 3,060 | 3,085 | 3,050 | 3,080 | +15 | +0.5% | 38,200 |
2021/09/13 | 3,030 | 3,070 | 3,015 | 3,065 | +20 | +0.7% | 30,400 |
2021/09/10 | 2,981 | 3,045 | 2,974 | 3,045 | +47 | +1.6% | 52,800 |
2021/09/09 | 2,990 | 3,000 | 2,968 | 2,998 | +4 | +0.1% | 43,500 |
2021/09/08 | 2,980 | 2,999 | 2,964 | 2,994 | +14 | +0.5% | 36,900 |
2021/09/07 | 2,970 | 3,020 | 2,970 | 2,980 | +24 | +0.8% | 65,200 |
2021/09/06 | 2,949 | 2,968 | 2,928 | 2,956 | +39 | +1.3% | 36,600 |
2021/09/03 | 2,885 | 2,942 | 2,880 | 2,917 | +32 | +1.1% | 46,700 |
2021/09/02 | 2,929 | 2,933 | 2,875 | 2,885 | -57 | -1.9% | 68,700 |
2021/09/01 | 2,928 | 2,957 | 2,891 | 2,942 | +32 | +1.1% | 62,000 |
2021/08/31 | 2,900 | 2,925 | 2,889 | 2,910 | +9 | +0.3% | 42,700 |
2021/08/30 | 2,918 | 2,918 | 2,887 | 2,901 | +8 | +0.3% | 41,400 |
2021/08/27 | 2,859 | 2,893 | 2,856 | 2,893 | +35 | +1.2% | 36,000 |
2021/08/26 | 2,875 | 2,886 | 2,855 | 2,858 | -8 | -0.3% | 28,600 |
2021/08/25 | 2,866 | 2,898 | 2,827 | 2,866 | +9 | +0.3% | 45,300 |
2021/08/24 | 2,860 | 2,872 | 2,835 | 2,857 | +12 | +0.4% | 93,100 |
2021/08/23 | 2,820 | 2,861 | 2,818 | 2,845 | +44 | +1.6% | 97,200 |
2021/08/20 | 2,793 | 2,827 | 2,789 | 2,801 | +8 | +0.3% | 36,500 |
2021/08/19 | 2,709 | 2,809 | 2,701 | 2,793 | +92 | +3.4% | 112,600 |
2021/08/18 | 2,747 | 2,759 | 2,691 | 2,701 | -17 | -0.6% | 63,400 |
2021/08/17 | 2,732 | 2,750 | 2,710 | 2,718 | -6 | -0.2% | 59,300 |
2021/08/16 | 2,757 | 2,773 | 2,718 | 2,724 | -42 | -1.5% | 76,100 |
2021/08/13 | 2,715 | 2,778 | 2,707 | 2,766 | +65 | +2.4% | 67,100 |
2021/08/12 | 2,674 | 2,723 | 2,658 | 2,701 | +23 | +0.9% | 44,500 |
2021/08/11 | 2,660 | 2,682 | 2,635 | 2,678 | +24 | +0.9% | 29,800 |
2021/08/10 | 2,600 | 2,664 | 2,600 | 2,654 | +53 | +2% | 43,700 |
2021/08/06 | 2,621 | 2,633 | 2,600 | 2,601 | -37 | -1.4% | 41,100 |
2021/08/05 | 2,620 | 2,658 | 2,620 | 2,638 | +23 | +0.9% | 39,600 |
2021/08/04 | 2,637 | 2,647 | 2,607 | 2,615 | -20 | -0.8% | 51,700 |
2021/08/03 | 2,650 | 2,670 | 2,617 | 2,635 | -18 | -0.7% | 60,400 |
2021/08/02 | 2,538 | 2,710 | 2,530 | 2,653 | +115 | +4.5% | 169,900 |
2021/07/30 | 2,622 | 2,625 | 2,500 | 2,538 | -78 | -3% | 103,000 |
2021/07/29 | 2,629 | 2,634 | 2,567 | 2,616 | -9 | -0.3% | 240,600 |
2021/07/28 | 2,569 | 2,627 | 2,568 | 2,625 | +36 | +1.4% | 81,900 |
2021/07/27 | 2,575 | 2,605 | 2,550 | 2,589 | +32 | +1.3% | 74,100 |
2021/07/26 | 2,560 | 2,578 | 2,545 | 2,557 | +38 | +1.5% | 56,900 |
2021/07/21 | 2,500 | 2,551 | 2,486 | 2,519 | +27 | +1.1% | 67,900 |
2021/07/20 | 2,476 | 2,496 | 2,461 | 2,492 | -15 | -0.6% | 56,500 |
2021/07/19 | 2,502 | 2,520 | 2,487 | 2,507 | -11 | -0.4% | 44,100 |
2021/07/16 | 2,518 | 2,541 | 2,512 | 2,518 | -9 | -0.4% | 41,000 |
2021/07/15 | 2,496 | 2,540 | 2,495 | 2,527 | +55 | +2.2% | 62,000 |
2021/07/14 | 2,495 | 2,495 | 2,458 | 2,472 | -16 | -0.6% | 27,400 |
2021/07/13 | 2,450 | 2,491 | 2,424 | 2,488 | +44 | +1.8% | 59,400 |
2021/07/12 | 2,398 | 2,450 | 2,398 | 2,444 | +64 | +2.7% | 76,100 |
2021/07/09 | 2,368 | 2,384 | 2,322 | 2,380 | -17 | -0.7% | 81,500 |
2021/07/08 | 2,440 | 2,449 | 2,397 | 2,397 | -7 | -0.3% | 84,100 |
2021/07/07 | 2,421 | 2,444 | 2,403 | 2,404 | -27 | -1.1% | 45,400 |
2021/07/06 | 2,443 | 2,450 | 2,425 | 2,431 | -6 | -0.2% | 30,100 |
2021/07/05 | 2,459 | 2,476 | 2,437 | 2,437 | -12 | -0.5% | 32,000 |
901~
950
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ペプチド | 167,300円 | +5.0% | +1.5% | 0.00% | 14.31倍 | 3.81倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 385,500円 | +3.6% | +6.1% | 3.11% | 12.99倍 | 0.76倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 299,500円 | +7.9% | -3.3% | 2.67% | 8.33倍 | 0.86倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム